Lisinopril
NDC Package 67296-0622-1

11-digit billing NDC: 67296062201

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Lisinopril is hypertensionLisinopril tablets are indicated for the treatment of hypertension. Marketed by Redpharm Drug Inc., this product is identified by NDC 67296-0622 and is authorized under FDA application ANDA077321.

Identification & Billing

NDC Package Code
67296-0622-1
Package Description
30 TABLET in 1 BOTTLE
Product Code
11-Digit Billing Format
67296062201
RxNorm Crosswalk
RxCUI: 314076 - lisinopril 10 MG Oral Tablet

Clinical Specifications

Proprietary Name
Lisinopril
Dosage Form
-
Usage Information
HypertensionLisinopril tablets are indicated for the treatment of hypertension. They may be used alone as initial therapy or concomitantly with other classes of antihypertensive agents.Heart FailureLisinopril tablets are indicated as adjunctive therapy in the management of heart failure in patients who are not responding adequately to diuretics and digitalis.Acute Myocardial InfarctionLisinopril tablets are indicated for the treatment of hemodynamically stable patients within 24 hours of acute myocardial infarction, to improve survival. Patients should receive, as appropriate, the standard recommended treatments such as thrombolytics, aspirin and beta-blockers.In using lisinopril tablets, consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen vascular disease, and that available data are insufficient to show that lisinopril tablets does not have a similar risk. (See WARNINGS).In considering the use of lisinopril tablets, it should be noted that in controlled clinical trials ACE inhibitors have an effect on blood pressure that is less in Black patients than in non-Blacks. In addition, ACE inhibitors have been associated with a higher rate of angioedema in Black than in non-Black patients (see WARNINGS, Anaphylactoid and Possibly Related Reactions ).

Regulatory & Marketing

Labeler Name
Redpharm Drug Inc.
FDA Application #
ANDA077321
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
11-17-2005
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (67296-0622). Click a package code to view its specific billing and regulatory data.

60 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 67296-0622-1 identifies a specific commercial package of 30 tablet in 1 bottle of Lisinopril, labeled by Redpharm Drug Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Redpharm Drug Inc. on November 17, 2005. The current certification is valid through December 31, 2017.

How is this Redpharm Drug Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 67296062201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
67296-0622-1
11-Digit CMS (5-4-2)
67296-0622-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.